Suven Life Sciences Quarterly Results for Trading Insights
SUVEN • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-77 Cr
QSept 2025
Suven Life Sciences Quarterly Results Key Highlights
- Revenue of ₹5 Cr in Sept 2025 (+66.7% vs Mar 2025, -28.6% vs Sept 2024)
- Net Profit of ₹-77 Cr in Sept 2025 (-75.0% vs Mar 2025, -54.0% vs Sept 2024)
- EBITDA of ₹-76 Cr in Sept 2025 (-76.7% vs Mar 2025)
- Operating Margin of -8671.0% in Sept 2025 (-5690.0pp vs Mar 2025)
- Earnings Per Share of ₹-3.48 in Sept 2025 (-72.3% vs Mar 2025)
Suven Life Sciences Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 5 | 3 | 3 | 7 | 7 | 66.7% | -28.6% |
| Net Profit (₹ Cr) | -77 | -44 | -52 | -50 | -27 | - | - |
| EBITDA (₹ Cr) | -76 | -43 | -50 | -48 | -26 | - | - |
| EPS (₹) | -3.48 | -2.02 | -2.36 | -2.27 | -1.22 | - | - |
| Operating Margin (%) | -8671.0% | -2981.0% | -2714.0% | -2032.0% | -1267.0% | - | - |
Suven Life Sciences Share Price Trend Around Quarterly Results
Visualize Suven Life Sciences's 1-year price movement across quarterly results — ideal for logging trades in Suven Life Sciences share price
chart using Tickjournal. All values in ₹.
Related Pages for Suven Life Sciences
Additional stock information and data for SUVEN
Revenue Trend (₹ Cr)
Sept 2024
7
Jun 2025
3
Mar 2025
3
Sept 2025
5
Net Profit Trend (₹ Cr)
Sept 2024
-50
Jun 2025
-52
Mar 2025
-44
Sept 2025
-77
Operating Margin Trend (%)
Sept 2024
-2032.0%
Jun 2025
-2714.0%
Mar 2025
-2981.0%
Sept 2025
-8671.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Suven Life Sciences quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores